Drug · DIN 02397137
STRIBILD
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 20, 2012; first marketed December 20, 2012.
- Drug Identification Number (DIN)
- 02397137
- Company (DIN owner)
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat J05AR09
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ELVITEGRAVIR | 150 MG | |
| COBICISTAT | 150 MG | |
| EMTRICITABINE | 200 MG | |
| TENOFOVIR DISOPROXIL FUMARATE | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 26, 2012: NOC 13907New Drug Submission (NDS)